Арилжаа TransMedics Group Inc - TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts. Хувьцааны сүүлийн үеийн нийтлэлүүд

NVIDIA-ийн хувьцааны урьдчилсан төлөв: Q3 ашиг, гүйцэтгэх захирлын солигдолАНУ-ын хагас дамжуулагчийн аварга NVIDIA (NVDA) 2026 оны 11 дүгээр сарын 17-нд 2027 санхүүгийн оны гурав дахь улирлын 115.8 тэрбум долларын орлогыг зарлаж, энэ нь жилийн өмнөхөөс 103%-иар өссөн байна. Гуравдагч талын зорилтот үнэ болон техникийн шинжилгээг судлаарай. Өнгөрсөн гүйцэтгэл нь ирээдүйн үр дүнгийн найдвартай үзүүлэлт биш юм.
10 цагийн өмнө